It is commonly believed, and also true, that dMMR/MSI generates subclones with heterogenous genotypes and neoantigens, which stimulate anti-tumor response through higher TIL grade and expression of IFN-γ-related genes. This evidence concerns the gene IFNG and neoplasm.